Investor Center
A collection of stock and financial information on Nexscient.
Be part of the AI evolution.
[OTCQB: NXNT]
Corporate Resources
Our team of service providers sets new standards in excellence!
Corporate Counsel
Lockett+Horwitz
Foothill Ranch, CA 92610
(949) 540-6540
(949) 540-6578 fax
Jessica Locket, Esq.
[email protected]
Auditors
dbb McKennon
Newport Beach, CA 92660
(949) 200-3280
(949) 200-3281 fax
David Gosselin, CPA
[email protected]
Transfer Agent
VStock Transfer
Woodmere, NY 11598
(212) 828-8436
(646) 536-3179 fax
Luke Karen
[email protected]
EDGAR Filings
Discount Edgar
125 Wolf Road, Suite 100
Albany, NY 12205
(800) 373-5910
(800) 473-1002 fax
Kurt D. Benedict
[email protected]
Digital Marketing
B2i Digital
401 2nd Avenue
New York, NY 10010
(212) 579-4844
Vince Curatola
[email protected]
Where is Nexscient's corporate headquarters?
2029 Century Park East, Suite 400
Los Angeles, CA 90067 USA
(800) 680-7520
What year was Nexscient incorporated?
When does the company's fiscal year end?
Who are the members of the company's management and Board of Directors?
What is Nexscient's stock CUSIP number?
When did Nexscient go public?
Under what symbol and exchange does Nexscient stock trade?
Nexscient common stock is quoted on the OTCQB under the ticker symbol: NXNT.
Does Nexscient have a direct stock purchase plan?
For more information on direct investment opportunities, please contact us at [email protected].
What is Nexscient's stock price?
How do I get a copy of the company's financial statements and SEC filings?
Where can I find analyst coverage on Nexscient stock?
How do I buy stock in Nexscient?
Who is the company's transfer agent?
Who are Nexscient's independent public accountants?
How do I contact Nexscient's investor relations?
Who do I contact if my question has not been answered?
Sign Up and Receive
Email Alerts
Sign up and get the latest news and developments in your inbox.
Want to purchase Nexscient stock?
Nexscient is conducting an initial public offering (IPO) of its common stock. This is your opportunity to participate in AI, which is expected to be one of the most profound inflection points in human history.
The current prospectus is made available in the Company’s Registration Statement on Form S-1 (File No. 333-274532), declared effective by the Securities and Exchange Commission on November 13, 2023. This Prospectus sets forth the terms and conditions of the offering of Shares and the risks associated therewith are described.
